 Evgenia Gerasimovskaya
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasa Vasorum | 12 | 2023 | 33 | 5.180 |
Why?
| | Endothelial Cells | 11 | 2023 | 687 | 2.790 |
Why?
| | Pulmonary Artery | 19 | 2023 | 1016 | 2.180 |
Why?
| | Neovascularization, Pathologic | 5 | 2020 | 281 | 1.730 |
Why?
| | Hypoxia | 7 | 2021 | 958 | 1.310 |
Why?
| | Adenosine Triphosphate | 7 | 2020 | 430 | 1.300 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2020 | 14 | 1.130 |
Why?
| | Cattle | 16 | 2023 | 920 | 1.080 |
Why?
| | Hypertension, Pulmonary | 6 | 2023 | 1729 | 1.070 |
Why?
| | Adventitia | 3 | 2023 | 37 | 1.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 6 | 2020 | 329 | 0.920 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 7 | 0.890 |
Why?
| | Vascular Remodeling | 3 | 2023 | 153 | 0.880 |
Why?
| | Neovascularization, Physiologic | 3 | 2016 | 173 | 0.860 |
Why?
| | Butyrates | 1 | 2021 | 53 | 0.730 |
Why?
| | Lung | 8 | 2023 | 3561 | 0.710 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2020 | 398 | 0.710 |
Why?
| | Adenosine | 2 | 2020 | 203 | 0.700 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 13 | 0.690 |
Why?
| | Endothelium | 1 | 2020 | 111 | 0.680 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.680 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 144 | 0.660 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 130 | 0.650 |
Why?
| | Signal Transduction | 10 | 2020 | 4516 | 0.650 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2020 | 117 | 0.640 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 367 | 0.570 |
Why?
| | Apyrase | 2 | 2018 | 14 | 0.540 |
Why?
| | 5'-Nucleotidase | 2 | 2018 | 35 | 0.530 |
Why?
| | Pneumonia | 1 | 2021 | 568 | 0.520 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 155 | 0.510 |
Why?
| | Cell Hypoxia | 7 | 2018 | 221 | 0.510 |
Why?
| | Glycolysis | 1 | 2016 | 227 | 0.500 |
Why?
| | rhoA GTP-Binding Protein | 2 | 2019 | 73 | 0.490 |
Why?
| | Fibroblasts | 9 | 2019 | 838 | 0.480 |
Why?
| | rho-Associated Kinases | 2 | 2019 | 80 | 0.470 |
Why?
| | Protein Kinases | 3 | 2007 | 307 | 0.470 |
Why?
| | Animals | 25 | 2023 | 31709 | 0.460 |
Why?
| | Receptor, Adenosine A1 | 1 | 2013 | 11 | 0.430 |
Why?
| | Antigens, CD | 2 | 2014 | 442 | 0.410 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1727 | 0.410 |
Why?
| | Actin Cytoskeleton | 1 | 2013 | 93 | 0.400 |
Why?
| | Macrophages | 3 | 2021 | 1263 | 0.380 |
Why?
| | Extracellular Space | 3 | 2009 | 116 | 0.380 |
Why?
| | Proto-Oncogene Proteins | 2 | 2004 | 608 | 0.370 |
Why?
| | Receptors, Purinergic P2Y1 | 1 | 2010 | 2 | 0.360 |
Why?
| | Cell Communication | 2 | 2012 | 280 | 0.360 |
Why?
| | Cell Proliferation | 10 | 2023 | 2187 | 0.360 |
Why?
| | Endothelium, Vascular | 4 | 2010 | 847 | 0.350 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2018 | 36 | 0.350 |
Why?
| | TOR Serine-Threonine Kinases | 5 | 2020 | 360 | 0.330 |
Why?
| | Calcium Signaling | 1 | 2010 | 217 | 0.310 |
Why?
| | Cells, Cultured | 9 | 2017 | 3886 | 0.290 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2007 | 22 | 0.290 |
Why?
| | Calcium | 1 | 2010 | 1108 | 0.240 |
Why?
| | Cell Movement | 5 | 2017 | 869 | 0.230 |
Why?
| | Enzyme Activation | 5 | 2017 | 785 | 0.230 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1737 | 0.230 |
Why?
| | Receptors, Purinergic | 2 | 2016 | 20 | 0.230 |
Why?
| | Cell Division | 2 | 2004 | 758 | 0.220 |
Why?
| | Adenosine Diphosphate | 3 | 2018 | 81 | 0.220 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2218 | 0.200 |
Why?
| | Biology | 1 | 2023 | 79 | 0.190 |
Why?
| | Systole | 1 | 2021 | 171 | 0.180 |
Why?
| | Tight Junctions | 1 | 2021 | 68 | 0.180 |
Why?
| | Microvessels | 1 | 2021 | 68 | 0.180 |
Why?
| | Acetylation | 1 | 2021 | 211 | 0.180 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 141 | 0.180 |
Why?
| | Metabolic Diseases | 1 | 2021 | 98 | 0.180 |
Why?
| | Animals, Newborn | 2 | 2014 | 778 | 0.180 |
Why?
| | Extracellular Fluid | 1 | 2020 | 30 | 0.170 |
Why?
| | Rats | 3 | 2021 | 4958 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 194 | 0.170 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 236 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 78 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 282 | 0.160 |
Why?
| | Laminin | 2 | 2009 | 69 | 0.150 |
Why?
| | Up-Regulation | 1 | 2021 | 808 | 0.150 |
Why?
| | Proteoglycans | 2 | 2009 | 107 | 0.150 |
Why?
| | Drug Combinations | 2 | 2009 | 287 | 0.150 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 89 | 0.140 |
Why?
| | Neprilysin | 1 | 2017 | 47 | 0.140 |
Why?
| | rho GTP-Binding Proteins | 1 | 2017 | 61 | 0.140 |
Why?
| | Male | 8 | 2020 | 55607 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2021 | 712 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2019 | 230 | 0.130 |
Why?
| | Collagen | 2 | 2009 | 415 | 0.130 |
Why?
| | Muscle Proteins | 1 | 2017 | 210 | 0.130 |
Why?
| | Blood Pressure | 1 | 2021 | 1538 | 0.120 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 411 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2020 | 1076 | 0.120 |
Why?
| | Myocardium | 1 | 2019 | 913 | 0.120 |
Why?
| | Cell Migration Assays | 1 | 2014 | 3 | 0.110 |
Why?
| | Colony-Forming Units Assay | 1 | 2014 | 88 | 0.110 |
Why?
| | Inflammation | 2 | 2023 | 2480 | 0.110 |
Why?
| | Cytokines | 1 | 2021 | 1841 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 57 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 63 | 0.110 |
Why?
| | Chromones | 1 | 2013 | 35 | 0.110 |
Why?
| | Oxadiazoles | 1 | 2013 | 32 | 0.110 |
Why?
| | Humans | 17 | 2023 | 114705 | 0.100 |
Why?
| | Blood Vessels | 2 | 2012 | 180 | 0.100 |
Why?
| | Morpholines | 1 | 2013 | 102 | 0.100 |
Why?
| | Rats, Nude | 1 | 2012 | 26 | 0.100 |
Why?
| | Osteopontin | 1 | 2012 | 32 | 0.100 |
Why?
| | Fluoresceins | 1 | 2012 | 46 | 0.100 |
Why?
| | DNA | 2 | 2009 | 1352 | 0.100 |
Why?
| | Telomerase | 1 | 2014 | 206 | 0.100 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2011 | 37 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2012 | 190 | 0.090 |
Why?
| | Dextrans | 1 | 2011 | 73 | 0.090 |
Why?
| | Capillary Permeability | 1 | 2011 | 139 | 0.090 |
Why?
| | Endothelin-1 | 2 | 2017 | 168 | 0.090 |
Why?
| | Purinergic Agonists | 1 | 2010 | 3 | 0.090 |
Why?
| | Ribosomal Protein S6 | 1 | 2010 | 15 | 0.090 |
Why?
| | Pertussis Toxin | 1 | 2010 | 26 | 0.090 |
Why?
| | Cyclic AMP | 1 | 2011 | 227 | 0.090 |
Why?
| | Pyridoxal Phosphate | 1 | 2010 | 20 | 0.090 |
Why?
| | Azo Compounds | 1 | 2010 | 25 | 0.090 |
Why?
| | Airway Remodeling | 1 | 2011 | 57 | 0.090 |
Why?
| | Models, Biological | 2 | 2021 | 1621 | 0.090 |
Why?
| | DNA Primers | 1 | 2011 | 510 | 0.090 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 301 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 146 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 164 | 0.080 |
Why?
| | Calcium Channels | 1 | 2010 | 145 | 0.080 |
Why?
| | Transport Vesicles | 1 | 2009 | 18 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 923 | 0.080 |
Why?
| | Regression Analysis | 1 | 2011 | 945 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 1147 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2011 | 1226 | 0.080 |
Why?
| | Cell Line | 2 | 2012 | 2637 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1140 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1629 | 0.070 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 83 | 0.070 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 157 | 0.070 |
Why?
| | Heart Failure | 1 | 2019 | 1945 | 0.070 |
Why?
| | Connective Tissue | 1 | 2006 | 36 | 0.070 |
Why?
| | Pulmonary Veins | 1 | 2006 | 81 | 0.060 |
Why?
| | Aorta | 1 | 2007 | 386 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2007 | 498 | 0.060 |
Why?
| | Oligonucleotides, Antisense | 1 | 2004 | 100 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 51 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2023 | 105 | 0.050 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 531 | 0.050 |
Why?
| | Sildenafil Citrate | 1 | 2023 | 57 | 0.050 |
Why?
| | Purines | 1 | 2023 | 159 | 0.050 |
Why?
| | Biomarkers | 1 | 2012 | 3408 | 0.050 |
Why?
| | Stem Cells | 3 | 2012 | 546 | 0.050 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 198 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2023 | 302 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2023 | 283 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 562 | 0.040 |
Why?
| | Time Factors | 1 | 2009 | 6116 | 0.040 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 71 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 55 | 0.040 |
Why?
| | Oxygen | 1 | 2003 | 854 | 0.040 |
Why?
| | Immune System | 1 | 2019 | 172 | 0.040 |
Why?
| | Leukocytes | 1 | 2019 | 276 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 54 | 0.040 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 13 | 0.040 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 7 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 316 | 0.040 |
Why?
| | Phenotype | 2 | 2017 | 2797 | 0.040 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 61 | 0.040 |
Why?
| | Microfilament Proteins | 1 | 2017 | 126 | 0.030 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 276 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 206 | 0.030 |
Why?
| | Mice | 1 | 2012 | 14872 | 0.030 |
Why?
| | Cell Differentiation | 3 | 2011 | 1701 | 0.030 |
Why?
| | Actins | 1 | 2017 | 381 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 449 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 932 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2018 | 445 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 1760 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2012 | 20 | 0.030 |
Why?
| | Cell Growth Processes | 1 | 2012 | 51 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2012 | 90 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2570 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 511 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 442 | 0.020 |
Why?
| | Vasculitis | 1 | 2011 | 66 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 916 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 378 | 0.020 |
Why?
| | Myofibroblasts | 1 | 2011 | 116 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 4694 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1569 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 396 | 0.010 |
Why?
| | Pulmonary Circulation | 1 | 2006 | 407 | 0.010 |
Why?
| | Gene Silencing | 1 | 2004 | 171 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2006 | 343 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2006 | 436 | 0.010 |
Why?
| | Nucleotides | 1 | 2002 | 112 | 0.010 |
Why?
| | Serotonin | 1 | 2003 | 292 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1021 | 0.010 |
Why?
| | Lung Diseases | 1 | 2006 | 701 | 0.010 |
Why?
| | Hypertension | 1 | 2006 | 1056 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2003 | 951 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2006 | 3535 | 0.010 |
Why?
| | Infant | 1 | 2002 | 7964 | 0.010 |
Why?
| | Child | 1 | 2002 | 18420 | 0.000 |
Why?
| | Adult | 1 | 2002 | 30553 | 0.000 |
Why?
|
|
Gerasimovskaya's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|